Admin
Pagină nouă: <p style="text-align: justify;"><br></p><p style="text-align: justify;">Previously, the COVID-19 vaccine maker estimated end-of-year revenue would land at $21 billion. But, on Thursday, it changed those expectations to between $18 and $19 billion. The company cited supply chain issues that have delayed its vaccine distribution for the revenue decline. Overall third-quarter net income for Moderna stands at $1.043 billion, down from $3.333 billion, or $7.70 a share, from the...